Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria

Peptides

Volumn 21, Issue 8, 2000, Pages 1155-1160

  Giacometti, Andrea ^a   Cirioni, Oscar ^a   Del Prete, Maria Simona ^a   Paggi, Alessandra Mataloni ^a   D'Errico, Marcello Mario ^a   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Bacteria; Peptides; Susceptibility tests; Synergy

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BUFORIN II; CECROPIN P1; CEFTAZIDIME; CEFTRIAXONE; CLARITHROMYCIN; CLINDAMYCIN; COLISTIN; DOXYCYCLINE; INDOLICIDIN; MAGAININ 2; MEROPENEM; NETILMICIN; OFLOXACIN; PEPTIDE DERIVATIVE; PIPERACILLIN; RANALEXIN; RIFAMPICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; DILUTION; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, LACTAM; ANTIBIOTICS, MACROLIDE; ANTIBIOTICS, PEPTIDE; ANTIBIOTICS, TETRACYCLINE; ANTIMICROBIAL CATIONIC PEPTIDES; CLARITHROMYCIN; COLISTIN; DOXYCYCLINE; DRUG INTERACTIONS; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MOLECULAR SEQUENCE DATA; PEPTIDES; PEPTIDES, CYCLIC; PROTEINS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 0033782330     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(00)00254-0     Document Type: Article

References (28)

1. Andreu D., Merrifield R.B., Steiner H., Boman H.G. N-terminal analogues of cecropin A synthesis, antibacterial activity and conformational properties . Biochemistry. 24:1985;1683-1688.
2. Blondelle S.E., Houghton R.A. Hemolytic and antimicrobial activities in the twenty-four individual omission analogues of mellitin. Biochemistry. 30:1991;4671-4678.
3. Boman H.G., Hultmark D. Cell-free immunity in insects. Annu Rev Microbiol. 41:1987;103-126.
4. Bone R.C. Gram-positive organisms and sepsis. Arch Intern Med. 154:1994;26-34.
5. Cannon M. A family of wound healers. Nature (London). 328:1987;478.
6. Clark D.P., Durell S., Maloy W.L., Zasloff M. Ranalexin a novel antimicrobial peptide from bullfrog (Rana catasbeiana) skin, structurally related to the bacterial antibiotic polymyxin . J Biol Chem. 269:1994;10849-10855.
7. DeLucca A.J., Blond J.M., Jacks T.J., Grimm C., Cleveland T.E., Walsh T.J. Fungicidal activity of cecropin A. Antimicrob Agents Chemother. 41:1997;481-483.
8. Falla T.J., Karunaratne D.N., Hancock R.E.W. Mode of action of the antimicrobial peptide indolicidin. J Biol Chem. 271:1996;303.
9. Falla T.J., Hancock R.E.W. Improved activity of a synthetic indolicidin analog. Antimicrob Agents Chemother. 41:1997;771-775.
10. Giacometti A., Cirioni O., Barchiesi F., Del Prete M.S., Scalise G. Antimicrobial activity of polycationic peptides. Peptides. 20:1999;1265-1273.
11. Hancock R.E.W. Peptides antibiotics. Lancet. 349:1997;418-422.
12. Hancock R.E.W. Antibacterial peptides and the outer membranes of gram-negative bacilli. J Med Microbiol. 46:1997;1-3.
13. Hancock R.E.W., Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother. 43:1999;1317-1323.
14. Howe R.A., Spencer R.C. Macrolides for the treatment of Pseudomonas aeruginosa infections? J Antimicrob Chemother. 40:1997;153-155.
15. Iketani M., Nishimura H., Akayama K., Yamano Y., Morishima I. Minimum structure of peptidoglycan required for induction of antibacterial protein synthesis in the silkworm, Bombyx mori. Insect Biochem Mol Biol. 29:1999;19-24.
16. Lee J.Y., Boman A., Chuanxin S., et al. Antimicrobial peptides from pig intestine isolation of a mammalian cecropin . Proc Natl Acad Sci USA. 86:1989;9159-9162.
17. Molinari G., Guzman C.A., Pesce A., Schito G.C. Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother. 31:1993;681-688.
18. Moore A.J., Beazley W.D., Bibby M.C., Devine D.A. Antimicrobial activity of cecropins. J Antimicrob Chemother. 37:1996;1077-1089.
19. National Committee for Clinical Laboratory Standards. Approved standards M7-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
20. Piers K.L., Hancock R.E.W. The interaction of a recombinant cecropin/mellitin hybrid peptide with the outer membrane of Pseudomonas aeruginosa. Mol Microbiol. 12:1994;951-958.
21. Raetz C.R.H. Biochemistry of endotoxins. Annu Rev Biochem. 59:1990;129-170.
22. Schletter K.H., Heine H., Ulmer A.J., Rietschel E.T. Molecular mechanisms of endotoxin activity. Arch Microbiol. 164:1995;383-389.
23. Vaara M., Porro M. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob Agents Chemother. 40:1996;1801-1805.
24. Viljanen P., Matsunaga H., Kimura Y., Vaara M. The outer membrane permeability-increasing action of deacylpolymyxins. J Antibiot. 44:1991;517-523.
25. Wade D., Boman A., Wåhlin B., et al. All-D amino acid-containing channel-forming antibiotic peptides. Proc Natl Acad Sci USA. 87:1990;4761-4765.
26. Yasuda H., Ajiki K., Koga T., Kawada H., Yokota T. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother. 37:1993;1749-1755.
27. Yi G.S., Park C.B., Kim S.C., Cheong C. Solution structure of an antimicrobial peptide buforin II. FEBS Lett. 398:1996;87-90.
28. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin isolation, characterization of two active forms, and partial cDNA sequence of a precursor . Proc Natl Acad Sci USA. 84:1987;5449-5453.